Neuphoria Therapeutics Inc (NEUP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -370 | -15,492 | -21,382 | -15,786 | -6,498 |
| Depreciation Amortization | 663 | 663 | 663 | 805 | 1,271 |
| Accounts receivable | 115 | 299 | 4,137 | -28 | 26 |
| Accounts payable and accrued liabilities | -918 | 804 | 374 | 711 | -47 |
| Other Working Capital | -497 | 1,455 | 4,585 | -4,064 | 1,220 |
| Other Operating Activity | 1,084 | -2,410 | -3,015 | 2,580 | -1,604 |
| Operating Cash Flow | $77 | $-14,681 | $-14,638 | $-15,784 | $-5,633 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 316 | -89 |
| PPE Investments | N/A | N/A | N/A | 126 | 26 |
| Other Investing Activity | 0 | 0 | 0 | 9 | 3 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $451 | $-60 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -8,284 |
| Common Stock Issued | 1,528 | 15,109 | 3,859 | 23,862 | 32,754 |
| Other Financing Activity | 0 | 0 | 0 | -4,277 | -893 |
| Financing Cash Flow | $1,528 | $15,109 | $3,859 | $19,585 | $23,577 |
| Exchange Rate Effect | -4 | 77 | -244 | -578 | -10 |
| Beginning Cash Position | 12,687 | 12,182 | 23,205 | 20,676 | 3,421 |
| End Cash Position | 14,289 | 12,687 | 12,182 | 24,351 | 21,295 |
| Net Cash Flow | $1,602 | $505 | $-11,023 | $3,675 | $17,874 |
| Free Cash Flow | |||||
| Operating Cash Flow | 77 | -14,681 | -14,638 | -15,784 | -5,633 |
| Capital Expenditure | N/A | N/A | N/A | -1 | -1 |
| Free Cash Flow | 77 | -14,681 | -14,638 | -15,785 | -5,634 |